Medication Safety, Medicine
19 results
Applied filters
Developing insulin safety across a system
16 February 2026Strategies, signposting and initiatives to support safer use of insulin.
Assessing injectables for enteral administration
2 January 2026Clinical decisions on the use of injectable formulations for enteral administration should be guided by safety and practicality.
Ensuring the safe use of amphotericin B injection
25 November 2025Amphotericin B liposomal products and Fungizone are not interchangeable. Take action to prevent death caused by inadvertent mis-selection
Ensuring time critical use of rasburicase
9 September 2025Timely use of rasburicase for treatment of tumour lysis syndrome is essential. Mitigation strategies can minimise harm associated with delayed therapy.
Minimising risks associated with administration of injectable iron
14 August 2025Administration of injectable iron has a risk of hypersensitivity and skin staining. Mitigation strategies can help minimise harm.
Managing the risk of confusion between injectable iron products
14 August 2025Minimising the risk of confusion between different injectable iron products may prevent inadvertent harm.
MSATS – Safe use of valproate
28 February 2024Discussion of key current medication safety challenges within healthcare with a focus on the safe use of valproate; inspiring partnership across the system
Developing opioid safety across a system
2 June 2025Strategies and signposting to support safer use of opioids for chronic, non-cancer pain.
Accessing resources for patients on high risk medicines
9 April 2025A number of resources are available to support the safe use of high-risk medicines. Healthcare professionals should ensure they are available for their patients
Using potassium permanganate for skin conditions or wound care
4 April 2025Potassium permanganate is a chemical product. We review the evidence for using it in wound care and highlight the risk of severe harm associated with wrong use.